Lactobacillus supplementation prevents cisplatin-induced cardiotoxicity possibly by inflammation inhibition.

The study here has established a possible role of microbiota dysbiosis in cisplatin-associated toxic effects, while delivery of Lactobacillus would be beneficial for the cardiac function prevention possibly via inflammation control.